The leaders changing the game in disease screening.


Under the guidance of CEO Dr. Stephen Graham and a seasoned leadership and advisory team, Breathe BioMedical is poised to change disease screening for years to come.


Stephen Graham, Ph.D

Dr. Stephen Graham has worked with the Company since 2015 and he led the recapitalization effort as well as secured capital funding for BBM. He was appointed as CEO of BBM in 2018. He leads BBM’s clinical research and business development. Stephen has valuable expertise in facilitating clinical research, knowledge translation, health care system innovation, and adoption of technology. With a PhD in Health Outcomes from the University of Florida, Gainesville, prior experience in the pharmaceutical industry and as a practicing pharmacist, Stephen has a strong understanding of innovation and the implementation of technology in the healthcare space.

Bill Dawes

Bill Dawes is responsible for business development activities as a leader for BBM’s business growth strategy and external partnerships. With over 25 years of Pharma and Diagnostic experience, Bill has expertise in business and operations functions within highly regulated, complex pharmaceutical manufacturing and global supply chain environments. Bill holds a B.Sc. in Mechanical Engineering from Hofstra University and recently completed the MIT Sloan School of Management’s Artificial Intelligence in Healthcare Program.

Chris Purves

Chris Purves co-developed Breathe BioMedical's technology. He leads BBM’s technology product development. Chris’ expertise lies in biophotonics, product design and development, process engineering, test engineering and ISO9000 implementation. Chris is a Professional Engineer and has a B.Sc. in Engineering Physics, University of Alberta, Edmonton.
Board Chair

Jean Nadeau

Jean Nadeau is a Biotech and Fintech investor. He has years of expertise and executive experience in venture start-ups, business reorganization, product development, growth acceleration, shareholder and media relations, and private fundraising. Jean’s corporate knowledge includes board experience with research centres, economic development agencies and academic institutions. His track record covers 30-years’ experience in IT and digital media, including at executive and senior leadership levels.

Peter Savas

Peter Savas is a serial life-science CEO, venture capitalist, (executive) director and advisor. He’s best known for financing and leading Aderis, the company that discovered, developed and partnered Neupro to treat people worldwide with Parkinson’s Disease and Restless Legs Syndrome. Peter is currently the CEO of LikeMinds, a brain health company; an advisor to AGP Life Science Ventures; and, a Breathe BioMedical director.

Gaëtan Thomas

Gaëtan Thomas is a New Brunswick pioneer with expertise in quality systems, safety systems, and operational excellence. Gaëtan is the former CEO of New Brunswick Power and has earned numerous awards for presence in the Atlantic provinces, including being a member of the Top 50 CEO Hall of Fame. Gaëtan is the current president and CEO of Conseil Économique du Nouveau Brunswick Inc.

Rahul Dhanda

Rahul Dhanda has built multiple companies as a CEO, Founder and Director. He has extensive experience as a commercial leader and scaling organizations at various development stages. Rahul is founding CEO of Syntis Bio and Sherlock Biosciences, and an advisor and founder of multiple other companies. Within diagnostics, Rahul most recently led Sherlock Biosciences to multiple milestones, including the first-ever commercial authorization by the FDA for a CRISPR product, whether therapeutic or diagnostic. As a result, Sherlock Biosciences was the first company to commercialize CRISPR as a product for clinical use. Rahul has an MBA from MIT Sloan School of Management and a BA from Wesleyan University.

Don Hardison

Don Hardison has a wide range of C-suite experience, with senior leadership experience in both public and private healthcare companies. He has specific expertise in raising private and public equity, strategy development, team building, and go-to-market planning and execution as well as deep experience in complex health care reimbursement framework and processes. Don is the former CEO of EXACT Sciences, a company dedicated to the early detection of cancer, and led the company through its Initial Public Offering (IPO). Don is also a former VP and C-Suite executive for multinational health care companies including Labcorp, Quest Diagnostics, and SmithKline Beecham (Now GSK). Most recently Don was the president and CEO of Biotheranostics Inc. which was acquired by Hologic in 2021.

Romeo Goguen

Romeo Goguen is a long-time leader in the New Brunswick Business Community. His expertise lies in entrepreneurship, business development, and growing companies. He is a past president of the Moncton Home Builders Association, and in 2017, he was inducted into the JA New Brunswick Business Hall of Fame.
Romeo is the founder and owner of Wildwood Cabinets, one the largest cabinet-making companies in Atlantic Canada, specializing in residential, commercial and multi-unit cabinetry, as well as solid surface countertops, employing over 160 people.
He is also the founder and owner of Les Entreprises Mapoma Ltée, which is in the real estate business, leasing commercial developments. It has over 150,000 square feet in 9 buildings


Breathe BioMedical has an amazing team of partners who conduct research with our technology and support our goals.